COVID-19给美国临床研究事业带来的新教训。 - Suppr

Suppr

超能文献

Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.

作者信息

Angus Derek C, Gordon Anthony C, Bauchner Howard

机构信息

UPMC and the University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania.

Senior Editor, JAMA.

出版信息

JAMA. 2021 Mar 23;325(12):1159-1161. doi: 10.1001/jama.2021.3284.

DOI:10.1001/jama.2021.3284

PMID:33635309

Abstract

摘要

相似文献

Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.

JAMA. 2021 Mar 23;325(12):1159-1161. doi: 10.1001/jama.2021.3284.

International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.

Vox Sang. 2021 Nov;116(10):1117-1135. doi: 10.1111/vox.13113. Epub 2021 May 20.

Response Letter: Treatment for emerging viruses: Convalescent plasma and COVID-19.

Transfus Apher Sci. 2021 Feb;60(1):102929. doi: 10.1016/j.transci.2020.102929. Epub 2020 Sep 1.

Covid-19 convalescent plasma and SARS-CoV-2 viral variants.

Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.

Convalescent plasma for COVID-19 considerations.

Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.

Use of Convalescent Plasma in the Management of COVID-19.

Mo Med. 2021 Mar-Apr;118(2):118.

Convalescent plasma therapy in patients with COVID-19.

Transfus Apher Sci. 2021 Feb;60(1):103017. doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19.

[COVID-19: blood sufficiency versus convalescent plasma?].

Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.

Convalescent plasma (CP) therapy in patients with COVID-19.

Transfus Apher Sci. 2021 Feb;60(1):103018. doi: 10.1016/j.transci.2020.103018. Epub 2020 Nov 19.

Appropriate selection of convalescent plasma donors for COVID-19.

Lancet Infect Dis. 2021 Feb;21(2):168-169. doi: 10.1016/S1473-3099(20)30470-9. Epub 2020 Jun 15.

引用本文的文献

Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.

Health Technol Assess. 2025 Aug;29(39):1-31. doi: 10.3310/POYW3311.

Health research versus the virus: strengthening systems, saving lives.

Health Res Policy Syst. 2025 Jul 25;23(1):95. doi: 10.1186/s12961-025-01354-4.

Hurdles for the Delivery of Multinational Randomized Clinical Trials.

JAMA Netw Open. 2025 Jul 1;8(7):e2518503. doi: 10.1001/jamanetworkopen.2025.18503.

How to build a better clinical trial ecosystem for future infectious disease emergencies in Japan: Findings from a narrative review and stakeholder meetings.

Glob Health Med. 2025 Apr 30;7(2):96-105. doi: 10.35772/ghm.2024.01082.

Barriers and facilitators to conducting human subjects research at a safety net institution from the perspective of researchers.

PLoS One. 2025 Jan 8;20(1):e0313530. doi: 10.1371/journal.pone.0313530. eCollection 2025.

Embedding clinical trial elements into clinical practice: Experiences from trial designers and implementers.

J Clin Transl Sci. 2024 Oct 17;8(1):202. doi: 10.1017/cts.2024.647. eCollection 2024.

Overcoming the barriers to better evidence generation from clinical trials.

Trials. 2024 Sep 16;25(1):614. doi: 10.1186/s13063-024-08460-8.

The response of Canada's clinical health research ecosystem to the COVID-19 pandemic.

CMAJ. 2024 Jun 16;196(23):E779-E788. doi: 10.1503/cmaj.230760.

The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.

JAMA. 2024 Jul 9;332(2):153-162. doi: 10.1001/jama.2024.4088.

The times are changing: A primer on novel clinical trial designs and endpoints in critical care research.

Am J Health Syst Pharm. 2024 Sep 9;81(18):890-902. doi: 10.1093/ajhp/zxae134.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.

JAMA. 2021 Mar 23;325(12):1159-1161. doi: 10.1001/jama.2021.3284.

International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.

Vox Sang. 2021 Nov;116(10):1117-1135. doi: 10.1111/vox.13113. Epub 2021 May 20.

Response Letter: Treatment for emerging viruses: Convalescent plasma and COVID-19.

Transfus Apher Sci. 2021 Feb;60(1):102929. doi: 10.1016/j.transci.2020.102929. Epub 2020 Sep 1.

Covid-19 convalescent plasma and SARS-CoV-2 viral variants.

Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.

Convalescent plasma for COVID-19 considerations.

Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.

Use of Convalescent Plasma in the Management of COVID-19.

Mo Med. 2021 Mar-Apr;118(2):118.

Convalescent plasma therapy in patients with COVID-19.

Transfus Apher Sci. 2021 Feb;60(1):103017. doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19.

[COVID-19: blood sufficiency versus convalescent plasma?].

Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.

Convalescent plasma (CP) therapy in patients with COVID-19.

Transfus Apher Sci. 2021 Feb;60(1):103018. doi: 10.1016/j.transci.2020.103018. Epub 2020 Nov 19.

Appropriate selection of convalescent plasma donors for COVID-19.

Lancet Infect Dis. 2021 Feb;21(2):168-169. doi: 10.1016/S1473-3099(20)30470-9. Epub 2020 Jun 15.

引用本文的文献

Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.

Health Technol Assess. 2025 Aug;29(39):1-31. doi: 10.3310/POYW3311.

Health research versus the virus: strengthening systems, saving lives.

Health Res Policy Syst. 2025 Jul 25;23(1):95. doi: 10.1186/s12961-025-01354-4.

Hurdles for the Delivery of Multinational Randomized Clinical Trials.

JAMA Netw Open. 2025 Jul 1;8(7):e2518503. doi: 10.1001/jamanetworkopen.2025.18503.

How to build a better clinical trial ecosystem for future infectious disease emergencies in Japan: Findings from a narrative review and stakeholder meetings.

Glob Health Med. 2025 Apr 30;7(2):96-105. doi: 10.35772/ghm.2024.01082.

Barriers and facilitators to conducting human subjects research at a safety net institution from the perspective of researchers.

PLoS One. 2025 Jan 8;20(1):e0313530. doi: 10.1371/journal.pone.0313530. eCollection 2025.

Embedding clinical trial elements into clinical practice: Experiences from trial designers and implementers.

J Clin Transl Sci. 2024 Oct 17;8(1):202. doi: 10.1017/cts.2024.647. eCollection 2024.

Overcoming the barriers to better evidence generation from clinical trials.

Trials. 2024 Sep 16;25(1):614. doi: 10.1186/s13063-024-08460-8.

The response of Canada's clinical health research ecosystem to the COVID-19 pandemic.

CMAJ. 2024 Jun 16;196(23):E779-E788. doi: 10.1503/cmaj.230760.

The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.

JAMA. 2024 Jul 9;332(2):153-162. doi: 10.1001/jama.2024.4088.

The times are changing: A primer on novel clinical trial designs and endpoints in critical care research.

Am J Health Syst Pharm. 2024 Sep 9;81(18):890-902. doi: 10.1093/ajhp/zxae134.